All Companies
LLYCongressional Stock Trades
Eli Lilly & Co.
Pharmaceutical Preparations
Congressional stock trades in Eli Lilly & Co. (LLY) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
53
Politicians Trading
22
Last Traded
Jul 10, 2026
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr.D | Jul 2, 2026 | Jun 10, 2026 | Buy | $50,001 - $100,000 | +1.46% |
| Gilbert Ray Cisneros, Jr.D | Dec 15, 2025 | Nov 18, 2025 | Buy | $1,001 - $15,000 | +11.93% |
| Jonathan L. JacksonD | Aug 25, 2025 | Apr 23, 2025 | Buy | $1,001 - $15,000 | +39.00% |
| Josh GottheimerD | Jun 11, 2025 | May 1, 2025 | Buy | $1,001 - $15,000 | +45.19% |
| Jonathan L. JacksonD | May 13, 2025 | Apr 21, 2025 | Buy | $15,001 - $50,000 | +40.94% |
Price History
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.